These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 773142)

  • 1. Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.
    Amery A; Billiet L; Boel A; Fagard R; Reybrouck T; Willems J
    Am Heart J; 1976 May; 91(5):634-42. PubMed ID: 773142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
    Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension.
    Fagard R; Amery A; De Plaen JF; Lijnen P; Missotten A
    Acta Cardiol; 1976; 31(5):411-26. PubMed ID: 14468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of atenolol in hypertensive patients.
    Ibrahim MM; Mossallam R
    Circulation; 1981 Aug; 64(2):368-74. PubMed ID: 7249304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension.
    Jensen HA; Rasmussen K; Mosbaek N
    Clin Sci Mol Med Suppl; 1976 Dec; 3():525s-526s. PubMed ID: 799562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol.
    Fagard R; Amery A; Deplaen JF; Lijnen P; Missotten A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():215s-217s. PubMed ID: 799551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
    Erina EV; Charyev KhE; Oshchepkova EV
    Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol and chlorthalidone in combination for hypertension.
    Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
    Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol once-daily in hypertension.
    Jeffers TA; Webster J; Petrie JC; Barker NP
    Br J Clin Pharmacol; 1977 Oct; 4(5):523-7. PubMed ID: 334211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of atenolol in hypertension.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Henningsen NC; Jameson S
    Clin Sci Mol Med Suppl; 1976 Dec; 3():513s-515s. PubMed ID: 799559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of cardiovascular response to the hypotensive effect of metoprolol.
    Fouad FM; Tarazi RC; Bravo EL
    Am Heart J; 1982 Oct; 104(4 Pt 1):803-11. PubMed ID: 7124594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.
    Takeda K; Nakagawa Y; Chin WP; Imai S
    Jpn J Pharmacol; 1982 Apr; 32(2):283-9. PubMed ID: 7098145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atenolol and bendrofluazide in hypertension.
    Petrie JC; Galloway DB; Webster J; Simpson WT; Lewis JA
    Br Med J; 1975 Oct; 4(5989):133-5. PubMed ID: 1104047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.
    Elliot MJ; Cullen PM; Phillips CI
    Br J Ophthalmol; 1975 Jun; 59(6):296-300. PubMed ID: 240378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.